775 reports of this reaction
3.6% of all LOPERAMIDE HYDROCHLORIDE ORAL reports
#4 most reported adverse reaction
INTENTIONAL PRODUCT USE ISSUE is the #4 most commonly reported adverse reaction for LOPERAMIDE HYDROCHLORIDE ORAL, manufactured by AMERISOURCE BERGEN. There are 775 FDA adverse event reports linking LOPERAMIDE HYDROCHLORIDE ORAL to INTENTIONAL PRODUCT USE ISSUE. This represents approximately 3.6% of all 21,604 adverse event reports for this drug.
Patients taking LOPERAMIDE HYDROCHLORIDE ORAL who experience intentional product use issue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
INTENTIONAL PRODUCT USE ISSUE is moderately reported among LOPERAMIDE HYDROCHLORIDE ORAL users, representing a notable but not dominant share of adverse events.
In addition to intentional product use issue, the following adverse reactions have been reported for LOPERAMIDE HYDROCHLORIDE ORAL:
The following drugs have also been linked to intentional product use issue in FDA adverse event reports:
INTENTIONAL PRODUCT USE ISSUE has been reported as an adverse event in 775 FDA reports for LOPERAMIDE HYDROCHLORIDE ORAL. This does not prove causation, but indicates an association observed in post-market surveillance data.
INTENTIONAL PRODUCT USE ISSUE accounts for approximately 3.6% of all adverse event reports for LOPERAMIDE HYDROCHLORIDE ORAL, making it a notable side effect.
If you experience intentional product use issue while taking LOPERAMIDE HYDROCHLORIDE ORAL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.